Pat Wechsler

• Generics May Limit Growth in Drug Spending

  By Pat Wechsler, Alex Nussbaum, Bloomberg  |  May 18, 2011

  Expiring patents mean $98 billion in savings for health plans, insurers

• Avoiding Cost Shock

  By Pat Wechsler  |  April 1, 2008

  Despite the options that a deregulated market for electricity offers, many businesses overlook opportunities to manage the exposure and ultimately gain more control over costs

• Rating the Rating Agencies

  By Pat Wechsler  |  March 1, 2008

  If investors can't depend on credit ratings, then why have them?

• The Blame Game

  By Pat Wechsler  |  March 1, 2008

  Finding a scapegoat is easy. Taking responsibility is the hard part.

• Dollar Dynamics

  By Pat Wechsler  |  February 1, 2008

  FIREapps' Wolfgang Koester deciphers how the dollar's frailty and comeback potential could wreak havoc on corporate financials

• ERM Comes of Age

  By Pat Wechsler  |  February 1, 2008

  After years of discussion, PCAOB's Auditing Standard 5 could--and should--finally make compliance programs relevant to how a business actually performs

• This CFO Never Sleeps

  By Pat Wechsler  |  December 28, 2007

  Three CFOs from some of the largest and most high profile companies around--Citigroup, Home Depot and Intel--share their thoughts on how finance can help steer a company's strategy through rough economic waters

• ANOTHER YEAR OF EXCELLENCE

  By Pat Wechsler  |  November 6, 2007

  Another year has almost run its course, and Treasury & Risk finds itself with another set of Alexander Hamilton Awards to hand out to a group ...

• Editor's Desk

  By Pat Wechsler  |  October 1, 2007

  I love the 40 Under 40 issue--although it is a painful reminder that even if I worked in a finance department or treasury and was ...

• Good or Good Enough?

  By Pat Wechsler  |  October 1, 2007

  MasterCard's Lori Byrne analyzes the pros and cons of putting your purchasing card program through a conversion study